RPL31
ribosomal protein L31, the group of L ribosomal proteins
Basic information
Region (hg38): 2:101002228-101024032
Links
Phenotypes
GenCC
Source:
No genCC data.
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (29 variants)
- Inborn genetic diseases (10 variants)
- not specified (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RPL31 gene is commonly pathogenic or not.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 5 | 1 | 6 | |||
missense | 4 | 1 | 5 | |||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | 1 | ||||
inframe indel | 1 | 1 | ||||
splice variant | 1 | 1 | ||||
non coding | 10 | 1 | 14 | 25 | ||
Total | 0 | 0 | 16 | 8 | 15 |
Variants in RPL31
This is a list of pathogenic ClinVar variants found in the RPL31 region.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-101002740-C-G | Likely benign (Oct 31, 2022) | |||
2-101002740-C-T | Likely benign (Sep 05, 2022) | |||
2-101002749-C-T | Benign (Oct 16, 2022) | |||
2-101002804-G-A | Uncertain significance (Sep 27, 2022) | |||
2-101002815-A-G | Likely benign (May 03, 2022) | |||
2-101002821-C-G | Benign (Nov 03, 2022) | |||
2-101002825-C-T | Likely benign (Sep 27, 2022) | |||
2-101002859-T-C | Benign (May 14, 2021) | |||
2-101002870-G-A | Benign (May 24, 2021) | |||
2-101002915-C-T | Benign (May 17, 2021) | |||
2-101004181-G-A | Uncertain significance (Sep 07, 2022) | |||
2-101004190-A-G | Inborn genetic diseases | Uncertain significance (May 04, 2022) | ||
2-101004198-C-T | Inborn genetic diseases | Uncertain significance (Jun 29, 2023) | ||
2-101004213-AAGG-A | Uncertain significance (May 25, 2022) | |||
2-101004263-T-C | Likely benign (Apr 12, 2022) | |||
2-101004304-C-G | Benign (May 18, 2021) | |||
2-101005769-C-T | Benign (May 14, 2021) | |||
2-101005947-T-A | Uncertain significance (Aug 24, 2022) | |||
2-101005977-C-T | not specified | Likely benign (Oct 26, 2022) | ||
2-101005985-G-A | Uncertain significance (Aug 10, 2022) | |||
2-101006029-C-T | Likely benign (Jul 19, 2022) | |||
2-101006060-C-A | Likely benign (Oct 17, 2022) | |||
2-101006165-C-A | Benign (May 24, 2021) | |||
2-101006266-C-T | Benign (May 14, 2021) | |||
2-101007861-C-T | Inborn genetic diseases | Uncertain significance (Jan 10, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
RPL31 | protein_coding | protein_coding | ENST00000409028 | 4 | 22318 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.850 | 0.148 | 122014 | 0 | 4 | 122018 | 0.0000164 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.64 | 39 | 80.4 | 0.485 | 0.00000487 | 820 |
Missense in Polyphen | 4 | 4.3461 | 0.92037 | 68 | ||
Synonymous | -0.198 | 28 | 26.7 | 1.05 | 0.00000123 | 261 |
Loss of Function | 2.31 | 0 | 6.22 | 0.00 | 3.53e-7 | 71 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000362 | 0.0000362 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Pathway
- Ribosome - Homo sapiens (human);Cytoplasmic Ribosomal Proteins;SRP-dependent cotranslational protein targeting to membrane;Eukaryotic Translation Initiation;Eukaryotic Translation Termination;Translation;Selenocysteine synthesis;Metabolism of proteins;Metabolism of amino acids and derivatives;Metabolism of RNA;Formation of a pool of free 40S subunits;Metabolism;Nonsense-Mediated Decay (NMD);Selenoamino acid metabolism;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC);L13a-mediated translational silencing of Ceruloplasmin expression;Peptide chain elongation;Eukaryotic Translation Elongation;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation
(Consensus)
Recessive Scores
- pRec
- 0.202
Intolerance Scores
- loftool
- rvis_EVS
- 0.24
- rvis_percentile_EVS
- 68.72
Haploinsufficiency Scores
- pHI
- 0.233
- hipred
- Y
- hipred_score
- 0.669
- ghis
- 0.413
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.824
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Low | Low |
Primary Immunodeficiency | Medium | Low | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Rpl31
- Phenotype
- endocrine/exocrine gland phenotype; reproductive system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); limbs/digits/tail phenotype;
Gene ontology
- Biological process
- nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;cytoplasmic translation;translation;translational initiation;SRP-dependent cotranslational protein targeting to membrane
- Cellular component
- cytosol;focal adhesion;membrane;cytosolic large ribosomal subunit;polysomal ribosome;extracellular exosome
- Molecular function
- RNA binding;structural constituent of ribosome;protein binding